By competing with miR-628-5p and regulating the IGF1R/Ras/Erk pathway, silencing hsa-circ-0006168 may inhibit the growth and motility of GBM cells [68] (Figure 4 and Table 2). Here, EPHB2 is linked to glioblastoma.